Article · Wikipedia archive · Last revised Jul 17, 2026

Flemming Ørnskov

Flemming Ørnskov is a Danish businessman. He has been the chief executive officer (CEO) of Galderma since October 2019.

Last revised
Jul 17, 2026
Read time
≈ 2 min
Length
429 w
Citations
17
Source
Wikipedia ↗
Flemming Ørnskov
Born (1958-01-24) 24 January 19581
Esbjerg, Denmark2
Alma materUniversity of Copenhagen
INSEAD
Harvard University
OccupationsCEO, Galderma
Children4

Flemming Ørnskov (born 24 January 1958) is a Danish businessman. He has been the chief executive officer (CEO) of Galderma3 since October 2019.

He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel.4 He previously worked for Bayer, Bausch & Lomb and Novartis.3

He is also the non-executive chairman of Waters Corporation, a position he's been holding since 2017.56

Ørnskov was educated at the Esbjerg Gymnasium.1 He received his MD from the University of Copenhagen, followed by an MBA from INSEAD, and a Master of Public Health (MPH) from Harvard University.7 Ørnskov is qualified as a doctor in Denmark and has experience as a practicing hospital physician.8

Ørnskov led Galderma's IPO on the Zurich stock exchange on March 22, 2024, one of the biggest offerings in Europe in years and the biggest in Switzerland since 2017.910 He declares Galderma plans to use the proceeds to pay down debt and invest in its pipeline.11

Ørnskov is married to a German management consultant, with whom he has two sons. He has one son and a daughter from a previous marriage.21

Awards

Top 100 Best-Performing CEOs in the World, 2015 - Harvard Business Review12

Top 25 Most Influential People in Biopharma Today, 2013 - Fierce Biotech13

References

References

  1. Goodman, Matthew (28 April 2013). "Dane who won't make a drama out of a drugs giant". The Sunday Times.
  2. Ward, Andrew (15 February 2015). "Monday interview: Flemming Ornskov, Shire CEO". Financial Times.
  3. Liu, Angus (October 8, 2019). "Ex-Shire CEO Flemming Ornskov emerges as Galderma CEO after $10B Nestlé spinout". Fiercepharma.
  4. "Shire chief finds right prescription for growth". The Telegraph. 29 December 2013. Retrieved 20 March 2014.
  5. "Conseil d'administration : Waters". www.waters.com. Retrieved 2021-04-01.
  6. "Waters Corporation Elects Flemming Ornskov to Board of Directors". Business Wire. June 2, 2017. Retrieved June 21, 2024.
  7. "Executive Profile: Flemming Ornskov". Bloomberg. Retrieved 4 September 2017.
  8. Clark, Andrew (26 April 2014). "Manifesto: maintaining a state of independence could be just what the doctor ordered". The Times.
  9. Swetha Gopinath and Allegra Catelli (2024-03-22). "Galderma Surges in Debut, Bolstering Europe IPO Recovery". www.bloomberg.com. Retrieved 2024-06-14.
  10. "GALDERMA STOCK SURGES IN DEBUT ON SWISS STOCK EXCHANGE SIX". Beauty Matter. 2024-03-22. Retrieved 2024-06-14.
  11. "EQT's Galderma Seeks to Raise $2.3 Billion in Swiss Listing". The Business of Fashion. 2024-03-07. Retrieved 2024-06-14.
  12. "The 'best-performing' CEO in the world is a pharma chief". BioPharma Dive. Retrieved 2021-04-01.
  13. "The 25 most influential people in biopharma today - 2013". FierceBiotech. 12 February 2013. Retrieved 2021-04-01.